Cargando…
Therapeutic drug monitoring of biologics in psoriasis
Biologics are an important component of the armamentarium of drugs in the treatment of moderate to severe psoriasis. There is increasing evidence that therapeutic drug monitoring (TDM) encompassing the measurement of trough concentrations and anti-drug antibodies (ADA), together with clinical respon...
Autores principales: | Liau, MeiQi May, Oon, Hazel H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613538/ https://www.ncbi.nlm.nih.gov/pubmed/31308623 http://dx.doi.org/10.2147/BTT.S188286 |
Ejemplares similares
-
Assessment and monitoring of biologic drug adverse events in patients with psoriasis
por: Hanley, Tessa, et al.
Publicado: (2016) -
Blinatumomab-associated vasculitis
por: Liau, MeiQi May, et al.
Publicado: (2017) -
Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013) -
Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
por: Valenzuela, Fernando, et al.
Publicado: (2021) -
Pemetrexed-induced eccrine squamous syringometaplasia manifesting as pseudocellulitis (in a patient with non–small cell lung cancer)
por: Santosa, Adinia, et al.
Publicado: (2017)